Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma
2006-001659-37Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sagopilone in glioblastoma (GBM), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Treatment success. Started Aug 2006; status: completed.
02
Drugs
sagopilone
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2006-001659-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001659-37.